Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Oncogenesis|February 10, 2018
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionalityGiulia Pinton, Stefan Nilsson, Laura MoroJournal of Thoracic Disease|April 12, 2021
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative reviewGiulia Pinton, Beatrice Manzotti, Cecilia Balzano, et al.Electromagnetic Biology and Medicine|March 11, 2020
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cellsGiulia Pinton, Angelo Ferraro, Massimo Balma, et al.Cancers|July 14, 2023
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1Enza Torre, Giulia Pinton, Grazia Lombardi, et al.Expert Opinion on Medical Diagnostics|March 14, 2013
Circulating tumor cells as a diagnostic test for malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Laura Moro, et al.Cancers|January 8, 2023
Epigenetic Insights on PARP-1 Activity in Cancer TherapyGiulia Pinton, Sara Boumya, Maria Rosa Ciriolo, et al.Oncotarget|July 31, 2019
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transitionOluseyi Ayinde, Zhuo Wang, Giulia Pinton, et al.Cancers|March 11, 2023
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural MesotheliomaMhd Ouis Al Khatib, Giulia Pinton, Laura Moro, et al.Expert Opinion on Investigational Drugs|July 3, 2013
Therapies currently in Phase II trials for malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Daniela Tavian, et al.Plos One|May 17, 2012
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Giovanni Angeli, et al.Pageof 4